Use of an HBV-DNA hybridization assay in the evaluation of equivocal hepatitis B virus tests in solid organ donors

Progress in Transplantation

Volumn 10, Issue 1, 2000, Pages 42-46

  Domen, R E ^a   Yen Lieberman, B ^a   Nelson, K A ^a   Chua, J ^a   Sholtis, W ^a   Tyus, H ^a   Isada, C M ^a  

^a INNOVISION COMMUNICATIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; ORGAN TRANSPLANTATION; VIRUS DETECTION;

EID: 0033855381     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.10.1.31037k70l5057170     Document Type: Article

References (24)

1. Paid-versus-volunteer blood donation in the United States: A historical review
2. Organ donor screening for infectious diseases
3. Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing
4. Results of a survey of infectious disease testing practices by organ procurement organizations in the United States
5. 'Occult' hepatitis B virus as source of infection in liver transplant recipients
6. Use of hepatitis B core antibody-positive multiorgan donors
7. The reinstatement of anti-HBc positive blood donors
8. A multicentre assessment of the specificity of ten anti-HBc screening tests
9. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine
10. Veterans Administration Hepatitis Cooperative Study Group Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen
11. Anticore antibody screening of transfused blood
12. Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population
13. Significance of isolated hepatitis B core antibody in blood donors
14. Liver transplantation and de novo hepatitis B infection [letter to the editor]
15. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBcAb(+), HBIgM(-) organ donors
16. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors
17. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease
18. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen
19. Infectivity of hepatic allografts with antibodies to hepatitis B virus
20. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants
21. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies
22. Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus D.N.A.
23. Detection and quantitation of HBV DNA by semi-nested PCR in donated blood: Comparison with HBV serological markers
24. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood